Skip to main content
Multiple local PfDHFR I164L haplotype expansions drive Plasmodium falciparum antifolate resistance in Uganda.
Dual activation of NLRP3 and pyrin inflammasomes mediates host responses to the human fungal pathogen Coccidioides.
Slowing the spread of treatment failure to artemisinin-based combination therapies in Uganda.
Target Trial Emulation of Vaccine Effectiveness in 5- to 17-years-olds with Prior SARS-CoV-2 Infection.
Potent acridone antimalarial against all three life stages of Plasmodium.
Integrating a host biomarker with a large language model for diagnosis of lower respiratory tract infection.
Characterizing and controlling CRISPR repair outcomes in nondividing human cells.
Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort.
Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024.
Risk of neuropsychiatric and related conditions associated with SARS-CoV-2 infection: a difference-in-differences analysis.